Ascend Laboratories, LLC recalled 2,256 bottles of Aripiprazole Tablets on August 28, 2025. The recall followed reports that the drug may be superpotent, posing serious health risks. Consumers should stop using the product immediately and consult healthcare providers.
Superpotent drug
Consumers and healthcare providers should stop using this product immediately. Contact Ascend Laboratories, LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Aripiprazole Tablets, USP, 10 mg, sold in 30-count bottles. The lot number is 24144162 and the expiration date is September 2027. The tablets were manufactured by Alken Laboratories Ltd., India, and distributed nationwide by Ascend Laboratories, LLC.
The recall stems from concerns that the Aripiprazole Tablets may be superpotent. This increased potency can lead to severe side effects and adverse reactions in patients.
There are no specific incident reports or injury counts mentioned. However, the potential for serious health risks from superpotent drugs categorizes this recall as high risk.
Consumers and healthcare providers should stop using Aripiprazole Tablets immediately. Contact Ascend Laboratories, LLC for guidance or consult your healthcare provider.
For more information, reach Ascend Laboratories, LLC at their office in Parsippany, NJ. Visit the FDA's recall page for further details.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.